Møller P, et al. Cancer incicence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrom database. Gut. 2017 Mar;66(3):464-472.
Cheng TH, et al. Five endometriaal cancer risk loci identified through genome-wide association analysis. Nat Genet. 2016 Jun;48(6):667-74.
Movahedi M, et al. Obesity, Aspirin and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. J Clin Oncol. 2015 Nov 1;33(31):3591-7.
Michailidou K. et al. Genome-wide association analysis of more than 120.000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015 Apr;47(4):373-80.
ten Broeke SW, et al. Lynch syndrom caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol. 2015 Feb 1;33(4):319-25.
Kuchenbaecker KB, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb;47(2):164-71.
Kontham V, von Holst S, Lindblom, A. Linkage analysis in familial non-Lynch syndrome colorectal cancer families from Sweden. PLoS One. 2013 Dec 11;8(12):e83936.
Bojesen SE, et al. Multiple independent variants at the TERT locus ar associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr;45(4):371-84, 384e1-2.
Dunlop MG, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat Genet. 2012 May 27;44(7):770-6.
Burn J, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011 Dec 17;378(9809):2081-7.
Platten U, Rantala J, Lindblom A, Brandberg Y, Lindgren G, Arver B. The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome. Fam Cancer. 2012 Sep;11(3):371-9.